MedTrace Logo

Primary Clinical Evaluation of Wearable Filtrating Artificial Kidney Device for On-site Medical Rescue

NCT05906355 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-06-15

No results posted yet for this study

Summary

Fluid overload is a common feature of diseases such as heart failure and kidney injury, which can lead to pulmonary edema or even death if not treated in time. In order to rapidly relieve fluid overload in patients, a wearable filtrating artificial kidney device was developed. The purpose of this study is to evaluation of the precision, security, and operability of wearable filtrating artificial kidney device for on-site medical rescue.

Conditions

  • Fluid Overload

Interventions

DEVICE

the wearable filtrating artificial Kidney Device

the wearable filtrating artificial kidney device rapidly for rapid relief of fluid overload in patients

DEVICE

traditional hemodialysis machine

the hemodialysis machine currently used in clinical practice to reduce fluid overload in patients

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-25
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05906355 on ClinicalTrials.gov